Vitamin D and Hypertension: Current Evidence and Future Directions
about
Calcium and phosphate impact cardiovascular risk.Dietary patterns and hypertension among Chinese adults: a nationally representative cross-sectional study.Vitamin D supplementation: what's known, what to do, and what's needed.Vitamin D, parathyroid hormone and their associations with hypertension in a Chinese population.The association of plasma resistin with dietary sodium manipulation, the renin-angiotensin-aldosterone system, and 25-hydroxyvitamin D3 in human hypertension.Vitamin D and vascular disease: the current and future status of vitamin D therapy in hypertension and kidney diseaseThe Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians.Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D studyThe influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men.25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians.Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension.The Role of Vitamin D in the Aging AdultRenin-angiotensin system activity in vitamin D deficient, obese individuals with hypertension: An urban Indian study.The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes.A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women.Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS.The renin-angiotensin-aldosterone system and calcium-regulatory hormonesAssociations between dietary patterns and hypertension among Korean adults: the Korean National Health and Nutrition Examination Survey (2008-2010).The relationship between maternal and fetal vitamin D, insulin resistance, and fetal growth.Association of Hyponatremia and Hypovitaminosis D in Ambulatory AdultsEffect of vitamin D supplementation on blood pressure in blacks.The Association Between Glycosylation of Immunoglobulin G and Hypertension: A Multiple Ethnic Cross-Sectional StudyVitamin D Deficiency and Cardio-Metabolic Risk in a North Indian Community with Highly Prevalent Type 2 DiabetesAssociation of Vitamin D Deficiency with Coronary Artery Disease.Vitamin D status, hypertension and body mass index in an urban black community in Mangaung, South Africa.Changes in blood pressure and lipid levels in young women consuming a vitamin D-fortified skimmed milk: a randomised controlled trial.The Relationship between Serum 25-Hydroxyvitamin D, Parathyroid Hormone and the Glomerular Filtration Rate in Korean Adults: The Korea National Health and Nutrition Examination Survey between 2009 and 2011.An estimate of the global reduction in mortality rates through doubling vitamin D levels.Vitamin D and cardiovascular risk.Association between vitamin D status and lipid profile in children and adolescents: a systematic review and meta-analysis.PTH and Vitamin D.Serum 25-hydroxyvitamin D is associated with incident peripheral artery disease among white and black adults in the ARIC study cohort.Vitamin D status is associated with cardiometabolic markers in 8-11-year-old children, independently of body fat and physical activity.Morning surge in blood pressure and sympathetic activity in Mongolians and Han Chinese: a multimodality investigation of hypertension and dyssomnia.Vitamin D and cardio-metabolic disease.Race/ethnicity, serum 25-hydroxyvitamin D, and heart disease.Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D.Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling.Relationship between vitamin D deficiency and nondipper hypertension.
P2860
Q27687570-B5FE3CE2-A79E-4A7C-BD7C-E3BB9700ACD6Q30509776-30C77FAF-825C-48BA-8B95-2FC9A6481316Q34264605-D1EAFF12-BC19-4CA2-BCCE-5A4EFE51222EQ34399080-0EBC32A1-439A-4EBF-96FB-A3E3373B65E6Q34691404-BAECF2B3-1ABA-4BAE-A84A-E6F56CEFD485Q34797562-F0014AAB-7DB7-4F12-889F-FF407B6B94D7Q34949335-D8FE09E2-FE1D-439A-88A9-887ED5F4A61EQ34967905-C96B4803-A801-4C34-AFA3-5F0D44A0CA76Q35013570-3E9FA49C-B907-412C-B38A-64114FFAD5F4Q35137614-78F40CA8-FC70-4AA5-8A25-C40075D50BC1Q35137622-3910C701-4666-4B79-A037-858B91BAAB41Q35443885-FA0CB056-211B-40A8-8BFF-27A45038D7DEQ35590943-6E91AB2B-06FC-434A-8D7D-9AC56A65FB08Q35791100-0BE89599-9434-4E84-A66A-05CA46D29535Q35793003-9556F95E-48F0-48AB-8569-BF96713DB64BQ36069813-7501FB90-80AD-4557-BF30-4509B83D8B34Q36288378-DC3E79BE-05D0-42C9-B91F-65BF66D13C38Q36626405-DFC0D767-6353-4504-84FA-28A1BB27E859Q36920415-0708BA46-7B62-4116-9F6F-8832BCAB2E78Q37019595-1DD883B6-5C84-4A29-9166-96FB0A2E07A1Q37041334-E2FD98C9-1B6F-4450-86F0-F8AC488454E3Q37178090-0807F3FE-F42F-4670-BE50-7DCED3164370Q37206320-BB64414E-DD63-4E30-A0CD-C6974B2BDB99Q37279083-DB95BC59-D18A-42BB-9A24-9AE024F1D79AQ37353060-66A364BF-46E4-4749-AF3E-D3574CA20EB9Q37409181-DD7151BA-A5E9-4860-B7B5-B523A65F541AQ37420472-E54F245B-3B1B-4FF1-8AE7-61EE8C7DFF58Q37689299-7E16246B-E37A-4BC1-A25F-8824E0D3868AQ37897923-35A39B35-1267-4169-B3DF-3D7D96596E50Q37997996-BAE34BF7-B5D4-4A0C-8BD0-4CA4B37E62C4Q38187704-F65B87DE-932D-4110-88C2-C964B14FD122Q38804461-9F8AF29E-4AB5-4DC8-B5BB-7A2CCEC4B392Q40360879-3AE69B04-3F32-402C-8ABF-AEEA6A2B17BAQ40526755-7C54DE69-9378-4C24-BDD9-ADB3D11331DCQ41694522-40EB1EB4-51F4-44B3-9C63-1FC3F6D32A9AQ42159607-D4489BC2-9FA8-462E-BFB2-6D0C7445CF73Q42389399-FA563EDF-A2DB-4922-AE4F-63E37A476D72Q44694720-6E031356-4F91-46B0-9F8D-A3C335728929Q44954648-D2D82F5B-DD4C-4587-ABB4-94A199159342Q46756625-6892C9B2-FB21-461F-A1C1-931E975CF3FE
P2860
Vitamin D and Hypertension: Current Evidence and Future Directions
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vitamin D and Hypertension: Current Evidence and Future Directions
@ast
Vitamin D and Hypertension: Current Evidence and Future Directions
@en
Vitamin D and Hypertension: Current Evidence and Future Directions
@en-gb
Vitamin D and Hypertension: Current Evidence and Future Directions
@nl
type
label
Vitamin D and Hypertension: Current Evidence and Future Directions
@ast
Vitamin D and Hypertension: Current Evidence and Future Directions
@en
Vitamin D and Hypertension: Current Evidence and Future Directions
@en-gb
Vitamin D and Hypertension: Current Evidence and Future Directions
@nl
altLabel
Vitamin D and hypertension: current evidence and future directions
@en
prefLabel
Vitamin D and Hypertension: Current Evidence and Future Directions
@ast
Vitamin D and Hypertension: Current Evidence and Future Directions
@en
Vitamin D and Hypertension: Current Evidence and Future Directions
@en-gb
Vitamin D and Hypertension: Current Evidence and Future Directions
@nl
P921
P3181
P1433
P1476
Vitamin D and Hypertension: Current Evidence and Future Directions
@en
P2093
J. P. Forman
P304
P3181
P356
10.1161/HYPERTENSIONAHA.109.140160
P407
P577
2010-10-11T00:00:00Z